We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NOUMED MOMETASONE HAYFEVER & ALLERGY RELIEF (NOUMED PHARMACEUTICALS PTY LTD)
Product name
NOUMED MOMETASONE HAYFEVER & ALLERGY RELIEF
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
171 (255 working days)
Active ingredients
mometasone furoate monohydrate
Registration type
New generic medicine
Indication
Noumed Mometasone Hayfever & Allergy Relief is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis for up to 6 months in adults and children 12 years of age and over.